Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Technological progress in generation of induced pluripotent stem cells for clinical applications

Oh SI., Lee CK., Cho KJ., Lee KO., Cho SG., Hong S.

Narrative Review, published in ScientificWorldJournal (2012) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
ScientificWorldJournal (2012)
Reported sample size
—
Source database
Europe PMC
PMID
22536140
PMCID
PMC3317624
DOI
10.1100/2012/417809
Citations
8

Abstract (original English)

Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is achieved by viral-mediated transduction of defined transcription factors. Generation of iPSCs is of great medical interest as they have the potential to be a source of patient-specific cells. For the eventual goal of clinical application, it is necessary to overcome the limitations of low reprogramming efficiency and chromosomal abnormalities due to viral DNA integration. In this paper, we summarize the current state of reprogramming technology for generation of iPSCs and also discuss potential approaches to the development of safe iPSCs for personalized cell-based replacement therapy.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Pluripotent Stem CellsHumansTranscription FactorsNuclear Transfer Techniques

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.